Article contents
Keeping up with the clinical advances: tardive dyskinesia
Published online by Cambridge University Press: 04 September 2019
Abstract
Tardive dyskinesia (TD) was first described in 1964, but treatment for this sometimes poorly characterized condition lagged decades as it was labored by medico-legal implications. TD has often been lumped with other medication-induced disorders and incorrectly classified as extrapyramidal symptoms. TD is likely to be under-recognized for many of these reasons. Though diverse in its presentations, TD is distinct in terms of time course, pathophysiology, and phenomenology.
- Type
- CME Review Article
- Information
- Copyright
- © Cambridge University Press 2019
Footnotes
This activity is supported by an unrestricted educational grant from Neurocrine Continental, Inc., a wholly-owned subsidiary of Neurocrine Biosciences, Inc.
References
REFERENCES:
- 1
- Cited by